Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: An open-label study

Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: An open-label study

10.1186/s12883-015-0267-7

Saved in:
Bibliographic Details
Main Authors: Kim J.-M., Chung S.J., Kim J.W., Jeon B.S., Singh P., Thierfelder S., Ikeda J., Bauer L., Sohn Y.-H., Lee M.S., Kim S.J., Cho J.W., Kim H.T., Park K.W., Lee H.-W., Irene L., Abd Aziz Z.B., Sim S.H., Tsai C.-H., Zheng T.-J., Wu R.-M., Schwartz R., Beran R., Evans A., Hayes M., Tan L., Tan E.K.
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: BioMed Central Ltd. 2018
Online Access:http://scholarbank.nus.edu.sg/handle/10635/144222
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/144222

Similar Items